Wee1

Wee1 Products

  • All (4)
  • Wee1 Inhibitors (4)
  • New Wee1 Products
Catalog No. Product Name Information Product Use Citations Product Validations
S1525 Adavosertib (MK-1775) Adavosertib (MK-1775, AZD1775) is a potent and selective Wee1 inhibitor with IC50 of 5.2 nM in a cell-free assay; hinders G2 DNA damage checkpoint. Phase 2.
Science, 2024, 384(6700):eadk0775
Nat Commun, 2024, 15(1):2089
EMBO J, 2024, 43(7):1301-1324
S8148 PD0166285 PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations (IC50=24 nM for Wee1 and 72 nM for Myt1). PD0166285 is also a novel G2 checkpoint abrogator. PD0166285 induces apoptosis.
Nat Commun, 2024, 15(1):2089
medRxiv, 2024, 2023.05.17.23290140
Nat Commun, 2023, 14(1):6088
S9778 Debio 0123 WEE1-IN-5 (Debio 0123) is a potent Wee1 inhibitor that inhibits phospho-CDC2 and abrogates the G2 check point.
medRxiv, 2024, 2023.05.17.23290140
E1000 Azenosertib (Zn-C3) Azenosertib (Zn-C3) is an oral active, highly effective and selective Wee1 inhibitor with IC50 of 3.9 nM, which can be used in cancer research.
medRxiv, 2024, 2023.05.17.23290140
S1525 Adavosertib (MK-1775) Adavosertib (MK-1775, AZD1775) is a potent and selective Wee1 inhibitor with IC50 of 5.2 nM in a cell-free assay; hinders G2 DNA damage checkpoint. Phase 2.
Science, 2024, 384(6700):eadk0775
Nat Commun, 2024, 15(1):2089
EMBO J, 2024, 43(7):1301-1324
S8148 PD0166285 PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations (IC50=24 nM for Wee1 and 72 nM for Myt1). PD0166285 is also a novel G2 checkpoint abrogator. PD0166285 induces apoptosis.
Nat Commun, 2024, 15(1):2089
medRxiv, 2024, 2023.05.17.23290140
Nat Commun, 2023, 14(1):6088
S9778 Debio 0123 WEE1-IN-5 (Debio 0123) is a potent Wee1 inhibitor that inhibits phospho-CDC2 and abrogates the G2 check point.
medRxiv, 2024, 2023.05.17.23290140
E1000 Azenosertib (Zn-C3) Azenosertib (Zn-C3) is an oral active, highly effective and selective Wee1 inhibitor with IC50 of 3.9 nM, which can be used in cancer research.
medRxiv, 2024, 2023.05.17.23290140

Choose Selective Wee1 Inhibitors

Wee1Signaling Pathway

Wee1信号通路图
Tags: Wee1 inhibitor|Wee1 agonist|Wee1 activator|Wee1 inducer|Wee1 antagonist|Wee1 signaling pathway|Wee1 assay kit